Stockscreener 앱 받기
1.79
4.79%
-0.09
시장 영업 전:
1.85
0.06
+3.35%
Tuhura Biosciences Inc 주식(HURA)의 최신 뉴스
TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday - MarketBeat
Portfolio Update: How is TuHURA Biosciences Inc managing supply chain issues2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Bull Bear: Is TuHURA Biosciences Inc a strong candidate for buy and hold2026 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
TuHURA Biosciences (NASDAQ:HURA) Trading Down 3.1%Here's Why - MarketBeat
Wall Street Zen Upgrades TuHURA Biosciences (NASDAQ:HURA) to "Hold" - MarketBeat
Market Rankings: What dividend growth rate does TuHURA Biosciences Inc offerTrade Entry Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
HURA Should I Buy - Intellectia AI
Aug PostEarnings: Will TuHURA Biosciences Inc outperform its industry peersPortfolio Gains Report & Capital Efficiency Focused Ideas - baoquankhu1.vn
HURA Technical Analysis & ETF Price Forecast - Intellectia AI
TuHURA Biosciences stock gains after Nasdaq compliance - Investing.com India
Update Recap: How is TuHURA Biosciences Inc managing supply chain issuesJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
TuHURA Biosciences stock gains after Nasdaq compliance By Investing.com - Investing.com South Africa
TuHURA Biosciences regains Nasdaq listing compliance - Investing.com
Cancer immunotherapy firm TuHURA keeps share price over $1 to satisfy Nasdaq - Stock Titan
Critical Review: Fate Therapeutics (NASDAQ:FATE) vs. TuHURA Biosciences (NASDAQ:HURA) - Defense World
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences - Nasdaq
HURA.O Technical Analysis & Stock Price Forecast - Intellectia AI
TuHURA Biosciences (HURA) to Release Earnings on Wednesday - MarketBeat
TuHura files IND for leukemia drug combination study By Investing.com - Investing.com India
TuHura files IND for leukemia drug combination study - Investing.com Australia
Tuhura Files Investigational New Drug Application for Tbs-2025 in the Treatment of Blood-Related Cancers - marketscreener.com
New TuHURA antibody aims to boost leukemia drug response - Stock Titan
Is TuHURA Biosciences Inc. a strong growth stockJuly 2025 Technicals & Technical Entry and Exit Tips - mfd.ru
HURA PE Ratio & Valuation, Is HURA Overvalued - Intellectia AI
Should I trade or invest in TuHURA Biosciences Inc.2025 Earnings Impact & Free Community Consensus Stock Picks - mfd.ru
Will TuHURA Biosciences Inc. (PL3) stock sustain bullish trend into 2025 - mfd.ru
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Malaysian Reserve
Cancer immunotherapy CEO to outline TuHURA’s work at Oppenheimer conference - Stock Titan
Will TuHURA Biosciences Inc. stock maintain dividend yieldWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru
HURA Stock Strongly Rises on Early Morning Surge - timothysykes.com
Is TuHURA Biosciences Inc. stock cheap at current valuationWeekly Trend Summary & Breakout Confirmation Alerts - mfd.ru
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Market Review: How volatile is Draganfly Inc stockTrade Risk Assessment & Smart Swing Trading Alerts - baoquankhu1.vn
FDA Grants Orphan Drug Status to Experimental Melanoma Therapy After Phase 1 Results - streetwisereports.com
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug By Investing.com - Investing.com South Africa
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - MEXC
TuHURA Receives FDA Orphan Drug Designation - Intellectia AI
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug - Investing.com
FDA Grants Orphan Drug Status to IFx-2.0 for Advanced Melanoma Care - Cure Today
Quarterly Earnings: What dividend growth rate does TuHURA Biosciences Inc offer2025 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice - TipRanks
TuHURA Biosciences Received Notice of Noncompliance - TradingView
Will TuHURA Biosciences Inc. outperform its industry peers2025 Volume Leaders & Safe Capital Investment Plans - mfd.ru
Risk Recap: How is TuHURA Biosciences Inc managing supply chain issuesJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn
Breakout Watch: How is TuHURA Biosciences Inc managing supply chain issuesWeekly Profit Summary & Weekly Setup with High ROI Potential - baoquankhu1.vn
TuHURA Biosciences (NASDAQ:HURA) Shares Up 0.5% – Here’s Why - Defense World
MACD Signal: Will TuHURA Biosciences Inc outperform its industry peers2025 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Will TuHURA Biosciences Inc. stock gain from lower inflation2025 Investor Takeaways & Expert Curated Trade Setup Alerts - Улправда
Will TuHURA Biosciences Inc. stock benefit from green energy trendsQuarterly Portfolio Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is TuHURA Biosciences Inc. stock supported by innovation pipelinePrice Action & Verified Momentum Stock Alerts - ulpravda.ru
1.20%
0.06%
자본화:
|
볼륨(24시간):